… The study was conducted to assess the safety and efficacy of a combined oral contraceptive,
YAZ, containing 3 mg drospirenone/20 μg ethinyl estradiol administered in a 24/4 regimen. …

… , the subjects were asked whether their libido was reduced, … tolerability and acceptability,
while maintaining efficacy. This … mg EE/0.06 mg gestodene, luteinized unruptured follicles were …

… acceptability and satisfaction and favourable body-weight control [Citation51]. The proportion
of women who experienced weight loss of 2 … obtained in women receiving either E4 5 mg/…

… a progestogen other than gestodene or desogestrel) and third-… Investigators for the two
other studies reported either no … and acceptance rates, and developing new contraceptive …

… valerate/dienogest and a monophasic combination of 17β − … drospirenone, desogestrel,
cyproterone acetate, gestodene, … this first study and the Danish study failed to infer whether CHC …

… Some of these short-term studies suggested small differences between monophasic and …
1993 including those involving the newer progestins (gestodene, norgestimate or desogestrel) …

… Desogestrel-containing monophasic and triphasic … Studies of the clinical acceptability and
effectiveness of the … carbohydrate metabolism for either gestodene or desogestrel use.28 Yet …

… but different progesterone (desogestrel or gestodene). Over the 6-cycle … monophasic oral
contraceptives containing either … 20 μg ethinylestradiol and either 150 μg desogestrel or 75 …

… monophasic oral contraceptives containing either drospirenone or desogestrel. Eur J …
containing ethinylestradiol and drospirenone. Eur J Contracept Reprod Health Care 2000; 5…

… 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel
… with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 μg and …